These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22509024)

  • 1. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.
    Kang R; Loux T; Tang D; Schapiro NE; Vernon P; Livesey KM; Krasinskas A; Lotze MT; Zeh HJ
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7031-6. PubMed ID: 22509024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway.
    Kang R; Tang D; Lotze MT; Zeh HJ
    Autophagy; 2012 Jun; 8(6):989-91. PubMed ID: 22722139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
    Kang R; Hou W; Zhang Q; Chen R; Lee YJ; Bartlett DL; Lotze MT; Tang D; Zeh HJ
    Cell Death Dis; 2014 Oct; 5(10):e1480. PubMed ID: 25341034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
    Vernon PJ; Loux TJ; Schapiro NE; Kang R; Muthuswamy R; Kalinski P; Tang D; Lotze MT; Zeh HJ
    J Immunol; 2013 Feb; 190(3):1372-9. PubMed ID: 23269246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
    DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
    J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival.
    Kang R; Tang D; Schapiro NE; Livesey KM; Farkas A; Loughran P; Bierhaus A; Lotze MT; Zeh HJ
    Cell Death Differ; 2010 Apr; 17(4):666-76. PubMed ID: 19834494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The advanced glycation end-product N
    Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
    J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of RAGE and Myd88 signaling in extensive liver resection.
    Zeng S; Zhang QY; Huang J; Vedantham S; Rosario R; Ananthakrishnan R; Yan SF; Ramasamy R; DeMatteo RP; Emond JC; Friedman RA; Schmidt AM
    FASEB J; 2012 Feb; 26(2):882-93. PubMed ID: 22075646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury.
    Kang R; Tang D; Livesey KM; Schapiro NE; Lotze MT; Zeh HJ
    Antioxid Redox Signal; 2011 Oct; 15(8):2175-84. PubMed ID: 21126167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
    Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
    Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer.
    Azizan N; Suter MA; Liu Y; Logsdon CD
    Biochem Biophys Res Commun; 2017 Nov; 493(1):592-597. PubMed ID: 28867179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.
    Mills LD; Zhang Y; Marler RJ; Herreros-Villanueva M; Zhang L; Almada LL; Couch F; Wetmore C; Pasca di Magliano M; Fernandez-Zapico ME
    J Biol Chem; 2013 Apr; 288(17):11786-94. PubMed ID: 23482563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.
    Kang R; Tang D; Schapiro NE; Loux T; Livesey KM; Billiar TR; Wang H; Van Houten B; Lotze MT; Zeh HJ
    Oncogene; 2014 Jan; 33(5):567-77. PubMed ID: 23318458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.
    Huang JS; Guh JY; Chen HC; Hung WC; Lai YH; Chuang LY
    J Cell Biochem; 2001; 81(1):102-13. PubMed ID: 11180401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.
    Baumgart S; Chen NM; Siveke JT; König A; Zhang JS; Singh SK; Wolf E; Bartkuhn M; Esposito I; Heßmann E; Reinecke J; Nikorowitsch J; Brunner M; Singh G; Fernandez-Zapico ME; Smyrk T; Bamlet WR; Eilers M; Neesse A; Gress TM; Billadeau DD; Tuveson D; Urrutia R; Ellenrieder V
    Cancer Discov; 2014 Jun; 4(6):688-701. PubMed ID: 24694735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
    Sato K; Hikita H; Myojin Y; Fukumoto K; Murai K; Sakane S; Tamura T; Yamai T; Nozaki Y; Yoshioka T; Kodama T; Shigekawa M; Sakamori R; Tatsumi T; Takehara T
    PLoS One; 2020; 15(7):e0235573. PubMed ID: 32609742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.